Nicole Rickman Media release: Guild supports increasing community pharmacists’ role and access to services The Pharmacy Guild of New Zealand (the Guild) supports increasing community pharmacists’ role and the funded services community pharmacies can provide, as announced today as part of ACT’s Pharmacy Fir... Advocacy Extended Pharmacy Services Funding Media release Aug 5, 2026
Glenn Mills Promising signs pharmacy environment is shifting despite challenges Pharmacy is undoubtedly facing challenges. Proposed ownership changes, funding issues, workforce constraints, poor prescribing quality and software challenges continue to have a significant daily impa... Advocacy Extended Pharmacy Services Funding Workforce Jul 31, 2026
Glenn Mills Interim Chief Executive reinforces focus I feel privileged and hugely excited to be stepping into this role. I’m looking forward to continuing to work alongside the Guild HQ team, Board, and wider stakeholders to achieve for members and our ... Advocacy Funding Pharmacy ownership Apr 30, 2026
Nicole Rickman Media release: Guild welcomes continued expansion of community pharmacy’s role The Pharmacy Guild of New Zealand (the Guild) supports the acknowledgement of the vital role of community pharmacy, with the announcement today that community pharmacists will be funded to directly pr... Advocacy Funding Media release Scope of practice Apr 15, 2026
Kesh Naidoo-Rauf 2025 reflections and looking ahead I want to acknowledge Andrew and his contribution to the Guild over the past 10 years. He has led the organisation through significant change – policy reform, a pandemic, and ongoing sector uncertaint... Advocacy Constitution Funding Pharmacy ownership Workforce Mar 31, 2026
Kesh Naidoo-Rauf Medicines shortages and use of unapproved medicines New Zealand, like many countries, struggles with medicines shortages. This issue increased during the height of the Covid-19 pandemic and unfortunately appears to be here to stay. New Zealand has a un... Advocacy Funding Workforce Feb 28, 2026
Andrew Gaudin Progress made in 2025 Positively influence pending legislative, regulatory and policy change Delivered full mitigation of the potential adverse fee impacts of 12-month prescriptions from 1 February 2026 – avoiding a mid-po... 12-month prescriptions Advocacy Funding NAAR Jan 31, 2026
Kesh Naidoo-Rauf Our priorities for 2026 Our purpose has always been clear: to support and advance the business and professional needs of community pharmacy. At the heart of this is our commitment to promote, protect, and strengthen the coll... 12-month prescriptions Advocacy Constitution Funding Pharmacy ownership Scope of practice Workforce Dec 31, 2025
Andrew Gaudin 12-month prescription mitigation We have worked intensely with key senior officials to resolve this issue since the government’s policy decision in May 2025. This has included working with officials at multiple levels and providing r... 12-month prescriptions Advocacy Funding NAAR Nov 30, 2025
Nicole Rickman Media release: Guild successfully mitigates 12-month prescription impacts The Pharmacy Guild of New Zealand (the Guild) is delighted that Health New Zealand (HNZ) has now agreed to funding changes to fully mitigate the financial impact of 12-month prescriptions for communit... 12-month prescriptions Funding Media release Nov 12, 2025
Kesh Naidoo-Rauf Sector workforce challenges New Zealand, like many countries, is facing a chronic pharmacy workforce shortage. This comes at a time when we are being asked to do more to relieve pressure from our general practice and hospital co... Advocacy Funding Workforce Oct 31, 2025
Andrew Gaudin NAAR process concerns Every year, the NAAR process is expected to be completed before 1 July, with any variations to the ICPSA from NAAR to be agreed by Voluntary Variation between ICPSA providers and HNZ. In 2024 and 2025... Advocacy Funding NAAR Oct 31, 2025